Carlyle, GTCR Ink $21.75-Per-Share Buyout Of AMRI
Life sciences research and development company Albany Molecular Research Inc. will be bought out by The Carlyle Group and GTCR LLC for $21.75 per share in cash, a 40 percent premium,...To view the full article, register now.
Already a subscriber? Click here to view full article